Chrysin: Chemistry, Occurrence, Pharmacokinetics, Toxicity, Molecular Targets, and Medicinal Properties of a Naturally Occurring Flavone
Authors:
- 1 October 2025
- journal article
- Published by Bentham Science Publishers Ltd. in Current Bioactive Compounds
- Vol. 21 (8) , 1-13
Abstract
The impact of naturally occurring flavonoids on human health and illnesses is crucial, as they are closely linked to dietary components and human health. Flavonoids may be able to shield people against disease in both in vitro and in vivo research settings. The flavonoid chrysin has demonstrated several intriguing pharmacological properties, including immune modulation, anti-cancer, anti-diabetic, antidepressant, and anti-asthmatic effects. Furthermore, it showed possible defenses against various toxins in the liver, brain, kidney, and heart, among other organs. Numerous investigations have been carried out to investigate potential targets for its potential mechanism of action. However, because of its low oral bioavailability, its medicinal uses have been restricted. Its broad first-pass metabolism is the leading cause of its low bioavailability. There hasn't been a thorough discussion of the pharmacological characteristics of chrysin and the molecular targets that are related to it yet. Therefore, this review aims to provide a comprehensive overview of chrysin, focusing on its chemical structure, natural sources, pharmacokinetics, toxicity profile, molecular targets, and medicinal properties. By synthesizing current research findings, this paper aims to highlight the therapeutic potential of chrysin, discuss its safety and efficacy, and identify areas for future research.Keywords
This publication has 103 references indexed in Scilit:
- Plant flavone Chrysin as an emerging histone deacetylase inhibitor for prosperous epigenetic‐based anticancer therapyPhytotherapy Research, 2020
- Impact of chrysin on the molecular mechanisms underlying diabetic complicationsJournal of Cellular Physiology, 2019
- Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transitionJournal of Molecular Medicine, 2015
- Chrysin and Luteolin Attenuate Diabetes‐Induced Impairment in Endothelial‐Dependent Relaxation: Effect on Lipid Profile, AGEs and NO GenerationPhytotherapy Research, 2013
- Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivoCancer, 2012
- Design, Synthesis, and Biological Evaluation of Bromophenol Derivatives as Protein Tyrosine Phosphatase 1B InhibitorsArchiv der Pharmazie, 2012
- Structural damage in diabetic nephropathy is associated with TNF-α system activityActa Diabetologica, 2011
- Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolinBiochemical Pharmacology, 2009
- Computational studies of the binding mechanism of calmodulin with chrysinBiochemical and Biophysical Research Communications, 2007
- Flavonoids in Food and Their Health BenefitsPlant Foods for Human Nutrition, 2004